Notably, targeting JMJD6 may provide additional ways to treat lung cancer, since suppressing JMJD6 via acetylating its upstream transcriptional factor HOXB9 resulted in a decrease in tumor growth and migration in xenograft models [138]. Here, JMJD6 is linked to lung carcinoma.